Navigation Links
Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
Date:10/27/2009

TOKYO and SAN FRANCISCO, Oct. 27 /PRNewswire-FirstCall/ -- Astellas Pharma Inc. ("Astellas") and Medivation, Inc. (Nasdaq: MDVN) announced today that they have entered into a global agreement to develop and commercialize MDV3100, Medivation's investigational drug for the treatment of prostate cancer. MDV3100 is currently being evaluated in the Phase 3 AFFIRM clinical trial in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.

Under the terms of the agreement, Medivation will receive an up-front cash payment of $110 million. Medivation is also eligible to receive payments of up to $335 million upon the attainment of development and regulatory milestones plus up to an additional $320 million in commercial milestone payments. The companies will collaborate on a comprehensive development program that will include additional studies to develop MDV3100 for both late- and early-stage prostate cancer. Subject to receipt of regulatory approval, the companies will jointly commercialize MDV3100 in the U.S. The companies will share equally all U.S. development costs, commercialization costs, and profits. Astellas will have responsibility for developing and commercializing MDV3100 outside the U.S. and will pay Medivation tiered double-digit royalties on ex-U.S. sales.

"We are pleased to initiate a great partnership with Medivation," stated Masafumi Nogimori, president and chief executive officer of Astellas. "We believe that MDV3100 has the unique potential to establish a new treatment approach for prostate cancer. Astellas already has the global expertise in urology and the strong commitment to focus on oncology. This partnership is a significant milestone to further expand our business in urology and to establish our franchise in oncology."

"We are excited t
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
2. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
3. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
4. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
5. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
6. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
7. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
8. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
11. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... 2013 Hemoglobin A1C levels increased over ... 2 diabetes, while modest improvements in A1C control ... can lead to substantial healthcare cost savings, according ... for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual ... by Valeritas, makers of the V-Go ® ...
(Date:5/22/2013)... 22, 2013   Life Line Screening  (LLS), ... today the creation of a unique partnership with ... MCM is a population health management organization. LLS ... of clients. These important expanded services will help MCM ... Effective prevention reduces cost of care when individuals are ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... 17, 2011 CVS Caremark (NYSE: CVS ... the position of President for Accordant Health Services, a ... management services for people with rare chronic conditions.  Murphy ... management programs with its specialty pharmacy programs and new ...
... Nov. 17, 2011 Global performance improvement solutions provider ... of GP Strategies Corporation (NYSE: GPX ), ... with INERCO (Seville, Spain), a ... and refining facilities with advanced combustion control technologies to ...
Cached Medicine Technology:CVS Caremark Appoints Kevin Murphy President of Accordant Business 2GP and INERCO Form Strategic Alliance to Assist Clients with Optimizing Fuel Costs and Decreasing Emissions 2GP and INERCO Form Strategic Alliance to Assist Clients with Optimizing Fuel Costs and Decreasing Emissions 3
(Date:5/23/2013)... To help members more easily ... pleased to announce integration of its advanced ... new upgrade automatically transfers real-time step data onto ... their company’s team standings, view progress on rewards, ... , Walkingspree also offers an integrated nutritional module ...
(Date:5/23/2013)... is pleased to announce the launch of BeatRUN™, an iPhone ... an iTunes library while running, walking, or on a treadmill. ... as a BPM remote, the app allows instructors to play ... in sync to match their fitness course. Featuring a fresh ... to the perfect beat and ensures their music will adjust ...
(Date:5/23/2013)... 2013 Great defined abs are the embodiment ... strives to achieve in the gym yet so many fall ... make this goal become a reality. Great abdominal muscles are ... time overlooked. Scott Tischler of Tischler Brothers Fitness explains four ... the goal of great abs. , 1.    Go to bed early. ...
(Date:5/23/2013)... May 23, 2013 Group Home Buy ... home buyers were taken on a tour of the latest ... people to purchase houses in groups, thus availing a concession ... charge a nominal fee from the home buyers for the ... the only source of revenue for Group Home Buy will ...
(Date:5/23/2013)... 2013 Kitchen on Fire ... the most advanced culinary technique series currently offered at ... the knowledge of how to purchase, butcher and cook ... benefits of organic, local ingredients. The new Intermediate Series ... hours each. The next series begins on Sunday, June ...
Breaking Medicine News(10 mins):Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3Health News:Kilo-Beat™ Launches “BeatRUN” App– Now Available on the App Store 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Group Home Buy, a Unique Facility for Home Buyers, Launched in Style 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 3
... from Boston Medical Centers (BMC) New England Centenarian ... their centenarian subjects, avoiding age-related diseases (i.e. stroke, ... to their longevity; rather, the avoidance of disability ... survival. These findings appear in the February 11th ...
... DIEGO, Feb. 11 SpectraScience, Inc. (OTC,Bulltetin ... devices company, today,announced that it has retained ... consulting firm to provide strategic investor relations,services., ... SpectraScience, stated, "We,have selected Hayden Communications because ...
... Call Center Activated ... to Support Recovery Efforts, NASHVILLE, ... of AT&T Inc. (NYSE: T ),today made a $60,000 ... the victims of this disaster, AT&T is,working with the Tennessee ...
... developed at MIT can deliver controlled drug doses to ... as a micro pharmacy. , The film could eventually ... and other diseases. It is among the first drug-delivery ... small electric field. , You can mete out what ...
... Inc. (Nasdaq:,ICAD), an industry-leading provider of Computer-Aided Detection ... announced that the,Company,s fourth quarter and year end ... on Thursday, March 6, 2008. iCAD management,will discuss ... 10:00 am,ET., Shareholders and other interested parties ...
... Part of MedCath,s Growth Plans, CHARLOTTE, N.C., Feb. ... physician partners today announced plans to double,the number of ... a 120-bed acute care and heart hospital., The ... into 60 inpatient beds, which will be used to ...
Cached Medicine News:Health News:Researchers at BMC find disability does not necessarily follow disease in living to old age 2Health News:SpectraScience, Inc. Retains Hayden Communications 2Health News:AT&T Tennessee Supports Local Disaster Relief Efforts 2Health News:AT&T Tennessee Supports Local Disaster Relief Efforts 3Health News:MIT develops thin-film 'micro pharmacy' 2Health News:iCAD To Release Fourth Quarter and Year End 2007 Financial Results on Thursday, March 6, 2008 2Health News:iCAD To Release Fourth Quarter and Year End 2007 Financial Results on Thursday, March 6, 2008 3Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 2Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: